Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes

INTRODUCTION: To evaluate the possibility that switching from reference biologic medicines to biosimilars could lead to altered clinical outcomes, including enhanced immunogenicity, compromised safety, or diminished efficacy for patients, a systematic literature review was conducted of all switching...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Hillel P., Blauvelt, Andrew, Rifkin, Robert M., Danese, Silvio, Gokhale, Sameer B., Woollett, Gillian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854749/
https://www.ncbi.nlm.nih.gov/pubmed/29500555
http://dx.doi.org/10.1007/s40265-018-0881-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854749/
https://www.ncbi.nlm.nih.gov/pubmed/29500555
http://dx.doi.org/10.1007/s40265-018-0881-y

Ejemplares similares